The Component AVITI Sequencing Platform’s novel Avidity Sequencing chemistry could be simply tailored to be used with the Bio-Rad SEQuoia Full Stranded RNA Library Prep Package and the SEQuoia Specific Stranded RNA Library Prep Package to acquire RNA sequencing accuracy and repeatability amongst samples and completely different RNA inputs.
The SEQuoia Full Stranded RNA Library Prep Package provides unbiased transcriptome profiling throughout RNA sequencing by capturing a broad vary of RNA subtypes in a single workflow, whether or not utilizing low or excessive enter RNA. The SEQuoia Specific Stranded RNA Library Prep Package provides the extra good thing about a extremely environment friendly 3-tube workflow for detection of lengthy RNAs that may be accomplished in solely 3 hours.
The Component AVITI System, a benchtop sequencer with wonderful efficiency, price financial savings, and adaptability, combines a easy workflow with distinctive information high quality. For enhanced experiment design freedom, the AVITI System options two circulate cells, every working independently, whereas sustaining the choice to ship as much as 2 billion reads of mixed sequencing output.
Latest collaborative research present excessive compatibility and efficiency for RNA sequencing utilizing SEQuoia library preparation chemistries on the Component AVITI System. Bio-Rad will current the outcomes of this collaboration on the Advances in Genome Biology and Expertise (AGBT) Common Assembly in Hollywood, Florida, on Thursday, February 9, at 8:00 AM in Presidential Suite 3131 of the Diplomat Resort Resort.
“The seamless integration of Component’s sequencing know-how with Bio-Rad’s SEQuoia portfolio helps allow cost-effective, versatile, and high-quality sequencing information for our prospects,” mentioned Shawn Levy, Chief Scientific Officer and Senior Vice President of Functions, Component Biosciences.
“We’re excited to work with Component to offer RNA library preparation chemistries providing excessive efficiency for a spread of pattern varieties. The collaboration with Component will be sure that our prospects can now entry this new sequencing platform in a ready-to-use format,” mentioned Steven Blakely, Senior Director for the Gene Expression Enterprise, Bio-Rad.
